OBN Digital Event:
'Accelerating Drug Discovery' 
Kindly hosted by Twist Bioscience

This edition of OBN’s Digital Event series is being organised in collaboration with Twist Bioscience and will focus on the biggest roadblocks for life science leaders and how these can be overcome using revolutionary technology

Increasing the speed at which drugs can be brought to market stands to directly impact both the patients who will benefit from these drugs, and the companies grappling with rising development costs and a diminishing rate of return.
 
In this discussion, OBN is joined by a panel of speakers all working to accelerate drug discovery. We’ll explore some of the key areas where improvements are being made - such as ensuring the right target, expanding the pool of high likelihood leads, or shortening development timelines - and discuss what roadblocks remain in development pipelines. Join us for what promises to be a fascinating discussion.

Event Host:
John Harris – CEO – OBN (UK) Ltd

Introduction from Twist Bioscience:
Ross Kettleborough – Technical Director, EMEA – Twist Bioscience

Case Study Presentations:
Milly Chen – Commercial Strategy Lead – Exscientia
Jonathan Hopper - Founder & VP of Platforms - Omass Therapeutics
Benedict Cross - CTO - PhoreMost

About the Event:
A live Q&A will follow the keynote presentations and audience members will be encouraged to engage with hosts regarding their thoughts on the technology, and personal experiences.

This session will be run in a live format, with registration open for both OBN Members and Non-Members.  A private partnering service will also be available for delegates to book meetings if required.

Please email your questions for the Q&A section of the event directly to: events@obn.org.uk

OBN Members - Complimentary
Non-Members - £25+VAT